Publications
Detailed Information
Critical view of anaphylaxis epidemiology: open questions and new perspectives
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tanno, Luciana K | - |
dc.contributor.author | Bierrenbach, Ana L | - |
dc.contributor.author | Simons, F. E R | - |
dc.contributor.author | Cardona, Victoria | - |
dc.contributor.author | Thong, Bernard Y | - |
dc.contributor.author | Molinari, Nicolas | - |
dc.contributor.author | Calderon, Moises A | - |
dc.contributor.author | Worm, Margitta | - |
dc.contributor.author | Chang, Yoon-Seok | - |
dc.contributor.author | Papadopoulos, Nikolaos G | - |
dc.contributor.author | Casale, Thomas | - |
dc.contributor.author | Demoly, Pascal | - |
dc.date.accessioned | 2018-05-28T05:01:49Z | - |
dc.date.available | 2018-05-28T14:03:41Z | - |
dc.date.issued | 2018-04-04 | - |
dc.identifier.citation | Allergy, Asthma & Clinical Immunology, 14(1):12 | ko_KR |
dc.identifier.issn | 1710-1492 | - |
dc.identifier.uri | https://hdl.handle.net/10371/140492 | - |
dc.description.abstract | Abstract
In contrast to the majority of allergic or hypersensitivity conditions, worldwide anaphylaxis epidemiological data remain sparse with low accuracy, which hampers comparable morbidity statistics. Data can differ widely depending on a number of variables. In the current document we reviewed the forms on which anaphylaxis has been defined and classified; and how it can affect epidemiological data. With regards to the methods used to capture morbidity statistics, we observed the impact of the anaphylaxis coding utilizing the World Health Organizations International Classification of Diseases. As an outcome and depending on the anaphylaxis definition, we extracted the cumulative incidence, which may not reflect the real number of new cases. The new ICD-11 anaphylaxis subsection developments and critical view of morbidity statistics data are discussed in order to reach new perspectives on anaphylaxis epidemiology. | ko_KR |
dc.description.sponsorship | This research was conducted with support from AstraZeneca, as an unrestricted AstraZeneca ERS-16-11927 Grant and from MEDA Pharma through CHRUM administration. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.subject | Anaphylaxis | ko_KR |
dc.subject | Classifcation | ko_KR |
dc.subject | Epidemiology | ko_KR |
dc.subject | International Classifcation of Diseases | ko_KR |
dc.subject | Rare diseases | ko_KR |
dc.subject | World Health Organization | ko_KR |
dc.title | Critical view of anaphylaxis epidemiology: open questions and new perspectives | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 장윤석 | - |
dc.identifier.doi | 10.1186/s13223-018-0234-0 | - |
dc.language.rfc3066 | en | - |
dc.rights.holder | The Author(s) | - |
dc.date.updated | 2018-04-08T03:29:38Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.